Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Renate Heyne"'
Autor:
Janett Fischer, Shuang Long, Eleni Koukoulioti, Tobias Müller, Balazs Fueloep, Renate Heyne, Mohammed Eslam, Jacob George, Fabian Finkelmeier, Oliver Waidmann, Thomas Berg, Florian van Bömmel
Publikováno v:
Pathogens, Vol 12, Iss 1, p 54 (2022)
Interleukin-1 beta (IL-1β) promotes liver disease progression and hepatocarcinogenesis in chronic hepatitis B (CHB). Single nucleotide polymorphisms (SNPs) within the promotor region of the IL-1β gene can affect the progression towards liver cirrho
Externí odkaz:
https://doaj.org/article/595d6d63d724474b8e8a6a7c4cf00179
Autor:
Peter Buggisch, Hans Heiken, Stefan Mauss, Bernd Weber, Maria-Christina Jung, Herbert Görne, Renate Heyne, Holger Hinrichsen, Dennis Hidde, Bettina König, Ana Gabriela Pires Dos Santos, Claus Niederau, Thomas Berg
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250833 (2021)
Despite the availability of highly effective and well-tolerated direct-acting antivirals, not all patients with chronic hepatitis C virus infection receive treatment. This retrospective, multi-centre, noninterventional, case-control study identified
Externí odkaz:
https://doaj.org/article/bad2952be92946c19e25d0cf762e3fcb
Autor:
Wolf Peter Hofmann, Peter Buggisch, Lisa Schubert, Nektarios Dikopoulos, Jeannette Schwenzer, Marion Muche, Gisela Felten, Renate Heyne, Patrick Ingiliz, Anna Schmidt, Kerstin Stein, Heiner Wedemeyer, Thomas Berg, Johannes Wiegand, Frank Lammert, Stefan Zeuzem, Jörn M. Schattenberg
Publikováno v:
JHEP Reports, Vol 2, Iss 6, Pp 100168- (2020)
Background & Aims: NAFLD is a growing health concern. The aim of the Fatty Liver Assessment in Germany (FLAG) study was to assess disease burden and provide data on the standard of care from secondary care. Methods: The FLAG study is an observational
Externí odkaz:
https://doaj.org/article/90039f920306409aa229b55d51c9a63b
Autor:
David Petroff, Olaf Bätz, Katrin Jedrysiak, Anja Lüllau, Jan Kramer, Hjördis Möller, Renate Heyne, Burkhard Jäger, Thomas Berg, Johannes Wiegand
Publikováno v:
Pathogens, Vol 10, Iss 12, p 1570 (2021)
(1) Background: Low rates of hepatitis C virus (HCV) diagnosis and sub-optimal linkage to care constitute barriers toward eliminating the infection. In 2012/2013, we showed that HCV screening in primary care detects unknown cases. However, hepatitis
Externí odkaz:
https://doaj.org/article/90d3d7c6f96549f5b581b2c92d5188bd
Autor:
Bernhard Schlevogt, Klaus H. W. Boeker, Stefan Mauss, Hartwig Klinker, Renate Heyne, Ralph Link, Karl-Georg Simon, Christoph Sarrazin, Yvonne Serfert, Michael P. Manns, Heiner Wedemeyer
Publikováno v:
Biomedicines, Vol 9, Iss 10, p 1495 (2021)
Chronic hepatitis C can be treated very effectively with direct-acting antivirals (DAA) with only minor side effects compared to an interferon-containing treatment regimen. The significance of metabolic comorbidities after HCV cure is not well define
Externí odkaz:
https://doaj.org/article/eda588095030462e95ce5bb2b8b02403
Autor:
Anne-Christin Beatrice Wilde, Charlotte Lieb, Elise Leicht, Lena Maria Greverath, Lara Marleen Steinhagen, Nina Wald de Chamorro, Jörg Petersen, Wolf Peter Hofmann, Holger Hinrichsen, Renate Heyne, Thomas Berg, Uwe Naumann, Jeannette Schwenzer, Johannes Vermehren, Andreas Geier, Frank Tacke, Tobias Müller
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5, p 1061 (2021)
Background: Clinical practice guidelines for patients with primary biliary cholangitis (PBC) have been recently revised and implemented for well-established response criteria to standard first-line ursodeoxycholic acid (UDCA) therapy at 12 months aft
Externí odkaz:
https://doaj.org/article/fd17b4a84053432cb3d3de56bee6cfed
Autor:
Jona T Stahmeyer, Siegbert Rossol, Florian Bert, Klaus H W Böker, Harald-Robert Bruch, Christoph Eisenbach, Ralph Link, Christine John, Stefan Mauss, Renate Heyne, Eckart Schott, Heike Pfeiffer-Vornkahl, Dietrich Hüppe, Christian Krauth
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159976 (2016)
Chronic hepatitis C virus infections (HCV) cause a significant public health burden. Introduction of telaprevir (TVR) and boceprevir (BOC) has increased sustained virologic response rates (SVR) in genotype 1 patients but were accompanied by higher tr
Externí odkaz:
https://doaj.org/article/86891e7aace0478981ef4dabc9c45612
Autor:
Florian van Bömmel, Kerstin Stein, Renate Heyne, Jörg Petersen, Peter Buggisch, Christoph Berg, Stefan Zeuzem, Andreas Stallmach, Martin Sprinzl, Eckart Schott, Anita Pathil-Warth, Ulrike von Arnim, Verena Keitel, Jürgen Lohmeyer, Karl-Georg Simon, Christian Trautwein, Andreas Trein, Dietrich Hüppe, Markus Cornberg, Frank Lammert, Patrick Ingiliz, Reinhart Zachoval, Holger Hinrichsen, Alexander Zipprich, Hartmuth Klinker, Julian Schulze zur Wiesch, Anett Schmiedeknecht, Oana Brosteanu, Thomas Berg
Publikováno v:
Journal of Hepatology. 78:926-936
Publikováno v:
39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.
Autor:
Pfefferkorn, Maria, Seltmann, Jonathan, Winkler, Romy, Wouambo, Rodrigue Kamga, Santisteve, Sara Sopena, Matz-Soja, Madlen, Buti, Maria, Renate, Heyne, Lampertico, Pietro, Berg, Thomas, van Bommel, Florian
Publikováno v:
In Journal of Hepatology June 2024 80 Supplement 1:S802-S803